Who owns AVENUE THERAPEUTICS INC?
- Ticker: ATXI
- CUSIP Number: 05360l304
Tip: Access positions for across all investors
Analyze quarterly positions in Avenue Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Avenue Therapeutics stock
Who bought or sold AVENUE THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Two Sigma Securities | 178k | $26k | 547% | Mar 2024 |
|
| Susquehanna International | 72k | $11k | 100% | Mar 2024 |
|
| Geode Capital Management | 52k | $7.7k | -1% | Mar 2024 |
|
| Vanguard Group | 46k | $6.8k | 0% | Mar 2024 |
|
| Hrt Financial | 46k | $6.0k | 83% | Mar 2024 |
|
| Jane Street | 30k | $4.4k | 100% | Mar 2024 |
|
| Millennium Management | 11k | $1.5k | -63% | Mar 2024 |
|
| Tower Research Capital | 8.9k | $1.3k | 29% | Mar 2024 |
|
| Wells Fargo & Company | 4.8k | $708.627600 | 4% | Mar 2024 |
|
| Royal Bank of Canada | 554.00 | $0 | 8% | Mar 2024 |
|
| Emfo | 533.00 | $78.990600 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 5.00 | $1.000000 | 100% | Mar 2024 |
|
Who sold out of Avenue Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2023 | 89k | $14k |
| Cubist Systematic Strategies | Dec 2023 | 11k | $1.8k |
| BlackRock | Sep 2023 | 1.9k | $1.3k |
| UBS Group | Dec 2023 | 1.1k | $173.988000 |
| Morgan Stanley | Sep 2023 | 276.00 | $194.994000 |
| Barrett & Company | Dec 2023 | 15.00 | $1.999500 |